Fumagalli, Giorgio Giulio
 Distribuzione geografica
Continente #
AS - Asia 2.470
NA - Nord America 2.116
EU - Europa 1.616
SA - Sud America 642
AF - Africa 58
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.920
Nazione #
US - Stati Uniti d'America 2.013
SG - Singapore 1.393
CN - Cina 595
IT - Italia 592
BR - Brasile 560
RU - Federazione Russa 239
GB - Regno Unito 186
LV - Lettonia 141
DE - Germania 135
ID - Indonesia 107
VN - Vietnam 107
HK - Hong Kong 103
AT - Austria 75
FI - Finlandia 63
CA - Canada 58
NL - Olanda 47
IN - India 40
MX - Messico 32
FR - Francia 29
AR - Argentina 24
EC - Ecuador 21
ZA - Sudafrica 19
BD - Bangladesh 18
IE - Irlanda 18
IQ - Iraq 18
AU - Australia 15
GR - Grecia 15
JP - Giappone 15
PK - Pakistan 12
ES - Italia 10
PL - Polonia 10
TR - Turchia 10
CL - Cile 8
AE - Emirati Arabi Uniti 7
MA - Marocco 7
PT - Portogallo 7
PY - Paraguay 7
SA - Arabia Saudita 7
SE - Svezia 7
VE - Venezuela 7
BE - Belgio 6
PE - Perù 6
UA - Ucraina 6
CH - Svizzera 5
DZ - Algeria 5
IR - Iran 5
JO - Giordania 5
KE - Kenya 5
TN - Tunisia 5
UZ - Uzbekistan 5
BG - Bulgaria 4
EG - Egitto 4
JM - Giamaica 4
UY - Uruguay 4
BO - Bolivia 3
CI - Costa d'Avorio 3
ET - Etiopia 3
RS - Serbia 3
AL - Albania 2
BN - Brunei Darussalam 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GE - Georgia 2
GH - Ghana 2
HN - Honduras 2
HU - Ungheria 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GM - Gambi 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
NA - Namibia 1
NC - Nuova Caledonia 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
UG - Uganda 1
Totale 6.920
Città #
Singapore 867
Ashburn 399
Trento 324
Dallas 265
Columbus 239
Santa Clara 239
Riga 141
Moscow 137
Hefei 125
Hong Kong 102
Jakarta 91
Los Angeles 81
Nuremberg 72
Washington 58
London 56
Redondo Beach 54
Buffalo 48
Chicago 48
São Paulo 48
New York 46
Beijing 45
Munich 42
Ho Chi Minh City 40
Milan 35
Lappeenranta 34
Rome 32
Salt Lake City 25
Vienna 24
Hanoi 21
Boardman 19
Rio de Janeiro 19
Amsterdam 16
Dublin 15
The Dalles 15
Belo Horizonte 14
Guangzhou 14
Turku 14
North Bergen 13
Tokyo 13
Curitiba 12
Tampa 12
Bassano del Grappa 11
Helsinki 11
Shanghai 11
Brooklyn 10
Denver 10
Mexico City 10
Ottawa 10
Toronto 10
Campinas 9
Elk Grove Village 9
Frankfurt am Main 9
Quito 9
Seattle 9
Brasília 8
Charlotte 8
Daiano 8
Islington 8
Montreal 8
Paris 8
Porto Alegre 8
Tempe 8
Warsaw 8
Athens 7
Brisbane 7
Dongguan 7
Guarulhos 7
Johannesburg 7
Kilburn 7
Salvador 7
Cavalese 6
City of London 6
Coventry 6
Florence 6
New Bedfont 6
Orem 6
Philadelphia 6
Phoenix 6
Poplar 6
Shenzhen 6
Sorocaba 6
Sterling 6
Thessaloniki 6
Tianjin 6
Zhengzhou 6
Acton 5
Benito Juarez 5
Changsha 5
Council Bluffs 5
Dhaka 5
Duque de Caxias 5
Falkenstein 5
Haiphong 5
Hangzhou 5
Houston 5
Hyderabad 5
Joinville 5
Natal 5
New Delhi 5
Prescot 5
Totale 4.328
Nome #
The search for a link between autism spectrum disorder and neurodegenerative dementia 201
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 108
Tango and physiotherapy interventions in Parkinson’s disease: a pilot study on efficacy outcomes on motor and cognitive skills 102
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 96
Mental State Recognition Deficits Linked to Brain Changes in Parkinson's Disease Without Dementia 94
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes 93
Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease 89
Utility of visual rating scales in primary progressive aphasia 88
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 84
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 83
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 81
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 77
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 76
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 75
Clinical Heterogeneity in Alzheimer’s Disease: A Possible New Amnesic Phenotype 72
Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers 71
The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint 67
MRI visual rating scales in the diagnosis of dementia: Evaluation in 184 post-mortem confirmed cases 66
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 66
Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study 66
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 64
The Italian fund for Alzheimer's and other dementias: strategies and objectives to face the dementia challenge 63
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 62
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 62
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status 60
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI) 59
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 59
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 59
Education modulates brain maintenance in presymptomatic frontotemporal dementia 58
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 58
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis 58
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 57
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 57
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 57
The potential of neurovascular modulation with tDCS: an exploratory analysis in older adults with hypertension. 57
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation 56
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 56
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 55
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 54
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic 54
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 53
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 53
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset 53
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 53
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 53
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 53
Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage 53
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters 52
Caregiver Tele-Assistance for Reduction of Emotional Distress during the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience 52
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 51
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 51
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study 51
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 50
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes 50
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 50
Teaching NeuroImage: Crowned Dens Syndrome: An Acute Attack of Calcium Pyrophosphate Deposition Disease Mimicking Acute Meningitis 49
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 49
Differential early subcortical involvement in genetic FTD within the GENFI cohort 49
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study 49
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort 49
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease 49
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration 49
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect 49
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia 48
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis 48
Altered plasma protein profiles in genetic FTD - a GENFI study 48
Disease-related cortical thinning in presymptomatic granulin mutation carriers 48
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 47
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 46
Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia 46
Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia 46
Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia 46
Sulcation morphology analysis for differentiating behavioral variant frontotemporal dementia from psychiatric disorders. 45
Unravelling the Association between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+? 45
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 45
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 45
Diogenes syndrome in dementia: a case report 45
Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study 45
White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study 44
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 44
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 44
Behavioral and neurophysiological effects of transcranial direct current stimulation (tDCS) in fronto-temporal dementia 44
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia 44
Alzheimer's disease diagnosis: Discrepancy between clinical, neuroimaging, and cerebrospinal fluid biomarkers criteria in an Italian cohort of geriatric outpatients: A retrospective cross-sectional study 44
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 44
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 43
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: A GENFI study 43
Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis 43
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 43
Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating Scales 43
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort 43
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 42
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 42
Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: Psychiatric clinical presentations 42
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 42
Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there? 42
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 42
Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease? 42
Diagnosis of Frontotemporal Dementia 41
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 41
Totale 5.725
Categoria #
all - tutte 47.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 480
Totale 48.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023528 0 0 0 50 255 99 26 26 25 5 10 32
2023/2024977 5 12 77 30 78 215 159 91 10 87 68 145
2024/20252.778 62 31 140 473 118 375 67 79 412 342 307 372
2025/20263.073 236 152 749 1.000 870 66 0 0 0 0 0 0
Totale 7.356